Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...

In 1967 mathematician Benoit Mandelbrot observed that the coastline of Great Britain is impossible to measure—its perimeter gets longer the more closely you measure it. At that point he was eight ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Abstract: This paper investigates the secure state estimation problem for time-varying singularly perturbed discrete sequential systems (SPDSSs) under bandwidth-constrained and multichannel-enabled ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. logos of OpenAI There’s interesting news coming from Sam Altman’s empire, a firm known for ...

Jason Blundell, a former creative lead on Activision Blizzard's Call of Duty: Black Ops series, has announced that he's formed a new development studio called Magic Fractal Studios. Blundell announced ...

SALT LAKE CITY, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and ...

PCWorld reports on Fractal Design’s new North Momentum Edition PC cases featuring an all-black aesthetic with blackened oak fronts and dark alloy accents. The Momentum Edition includes three upgraded ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...